Image courtesy of Confer Health
Confer Health said today that it raised $9.5 million to support its development of affordable, at-home diagnostic devices featuring interchangeable cartridges, a reusable analyzer and a mobile app.
The Boston, Mass.-based company’s first urine-based diagnostic test is designed to help couples conceive by tracking three fertility hormones.
Get the full story at our sister site, Drug Delivery Business News.
The post Confer Health raises $9.5m for fertility diagnostic appeared first on MassDevice.
from MassDevice https://ift.tt/2GWN1h0
Cap comentari:
Publica un comentari a l'entrada